Patents by Inventor Charles D. Estin

Charles D. Estin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant viruses encoding the human melanoma-associated antigen
    Patent number: 5262177
    Abstract: Peptides or proteins related to a melanoma associated antigen are described. These are produced in large quantities via recombinant DNA techniques and/or by chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which can induce an immune response that selectively destroys melanoma cells in a vaccinated individual. Where the peptides or proteins are expressed by a recombinant virus, inactivated or live virus vaccine formulations may be prepared.
    Type: Grant
    Filed: January 27, 1987
    Date of Patent: November 16, 1993
    Assignee: Oncogen
    Inventors: Joseph P. Brown, Charles D. Estin, Gregory D. Plowman, Timothy M. Rose, Karl E. Hellstrom, Ingegerd Hellstrom, Anthony F. Purchio, Shiu-Lok Hu, Sridhar Pennathur
  • Vaccines against melanoma
    Patent number: 5141742
    Abstract: Peptides or proteins related to a melanoma associated antigen are described. These are produced in large quantities via recombinant DNA techniques and/or by chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which can induce an immune response that selectively destroys melanoma cells in a vaccinated individual. Where the peptides or proteins are expressed by a recombinant virus, inactivated or live virus vaccine formulations may be prepared.
    Type: Grant
    Filed: May 13, 1991
    Date of Patent: August 25, 1992
    Assignee: Oncogen
    Inventors: Joseph P. Brown, Charles D. Estin, Gregory D. Plowman, Timothy M. Rose, Karl E. Hellstrom, Ingegerd Hellstrom, Anthony Purchio, Shiu-Lok Hu, Sridhar Pennathur